Pacira BioSciences, Inc.
PCRX· Nasdaq
Released Feb 28, 2019, after the close
10-K filed Feb 28, 2019, 59 days after period end · 0001396814-19-000008
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2018 | Q4 2017 | Q4 2016 | Q4 2015 |
|---|---|---|---|---|
| Revenue | $95.12M | $79.08M | $72.90M | $69.32M |
| Net Income | $8.29M | $4.60M | -$3.97M | -$2.50M |
| EPS Diluted | $0.20 |
Pacira BioSciences, Inc. · CIK 1396814 · Engraved from SEC EDGAR
| $0.11 |
| -$0.11 |
| -$0.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.